145 related articles for article (PubMed ID: 19615750)
1. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
[TBL] [Abstract][Full Text] [Related]
2. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.
Cui W; Lapointe M; Gauvreau D; Kalant D; Cianflone K
Mol Immunol; 2009 Oct; 46(16):3207-17. PubMed ID: 19767107
[TBL] [Abstract][Full Text] [Related]
3. The human complement fragment receptor, C5L2, is a recycling decoy receptor.
Scola AM; Johswich KO; Morgan BP; Klos A; Monk PN
Mol Immunol; 2009 Mar; 46(6):1149-62. PubMed ID: 19100624
[TBL] [Abstract][Full Text] [Related]
4. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
5. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
6. C5L2 is a functional receptor for acylation-stimulating protein.
Kalant D; MacLaren R; Cui W; Samanta R; Monk PN; Laporte SA; Cianflone K
J Biol Chem; 2005 Jun; 280(25):23936-44. PubMed ID: 15833747
[TBL] [Abstract][Full Text] [Related]
7. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
[TBL] [Abstract][Full Text] [Related]
8. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
9. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
10. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis.
Wang R; Lu B; Gerard C; Gerard NP
J Immunol; 2013 Oct; 191(8):4001-9. PubMed ID: 24043888
[TBL] [Abstract][Full Text] [Related]
12. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
13. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
Kalant D; Cain SA; Maslowska M; Sniderman AD; Cianflone K; Monk PN
J Biol Chem; 2003 Mar; 278(13):11123-9. PubMed ID: 12540846
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.
Braun L; Christophe T; Boulay F
J Biol Chem; 2003 Feb; 278(6):4277-85. PubMed ID: 12464600
[TBL] [Abstract][Full Text] [Related]
15. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
16. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.
Cui W; Paglialunga S; Kalant D; Lu H; Roy C; Laplante M; Deshaies Y; Cianflone K
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1482-91. PubMed ID: 17711993
[TBL] [Abstract][Full Text] [Related]
17. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
18. C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.
Poursharifi P; Lapointe M; Fisette A; Lu H; Roy C; Munkonda MN; Fairlie DP; Cianflone K
Mol Cell Endocrinol; 2014 Jan; 382(1):325-333. PubMed ID: 24397921
[TBL] [Abstract][Full Text] [Related]
19. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment.
Croker DE; Halai R; Kaeslin G; Wende E; Fehlhaber B; Klos A; Monk PN; Cooper MA
Immunol Cell Biol; 2014 Aug; 92(7):631-9. PubMed ID: 24777312
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia.
Marcil M; Vu H; Cui W; Dastani Z; Engert JC; Gaudet D; Castro-Cabezas M; Sniderman AD; Genest J; Cianflone K
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1619-25. PubMed ID: 16627811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
